A Newborn with Gastric Hemangioma Treated Using Propranolol.
10.5223/pghn.2018.21.4.341
- Author:
Huseyin KAYA
1
;
Ismail Kursad GOKCE
;
Sukru GUNGOR
;
Hatice TURGUT
;
Ramazan OZDEMIR
Author Information
1. Division of Neonatology, Department of Pediatrics, Turgut Ozal Medical Center, Inonu University School of Medicine, Malatya, Turkey. doctor_ctf@hotmail.com
- Publication Type:Case Report
- Keywords:
Hemangioma;
Newborn infant;
Propranolol;
Stomach
- MeSH:
Hemangioma*;
Hemorrhage;
Humans;
Infant, Newborn*;
Melena;
Propranolol*;
Somatostatin;
Stomach
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2018;21(4):341-346
- CountryRepublic of Korea
- Language:English
-
Abstract:
Gastric hemangiomas are rare benign vascular tumors that can cause severe gastrointestinal system bleeding. We presented the case of a neonate with fresh bleeding and melena from the orogastric tube and detected gastric hemangioma in esophagogastroduodenoscopic examination. Propranolol is widely used in treatment of cutaneous hemangiomas and non-gastric gastrointestinal system hemangiomas. However, the surgical approach is preferred for treating gastric hemangiomas, and there are few reports of gastric hemangiomas associated with non-surgical treatment. Gastric hemorrhage decreased with antacid and somatostatin treatment. Propranolol treatment was initiated before the surgery decision. After three weeks of treatment, we observed regression in the hemangioma with endoscopic evaluation. During the course of treatment, the patient's gastrointestinal system bleeding did not recur, and there were no side effects associated with propranolol.
